Testolactone Pregnancy and Breastfeeding Warnings
Testolactone is also known as: Teslac
Testolactone Pregnancy Warnings
Testolactone has been assigned to pregnancy category C by the FDA. Animal studies have revealed evidence of increased fetal mortality, increased abnormal fetal development, and increased mortality. There are no controlled data in human pregnancy. Testolactone is intended for use only in postmenopausal women. This drug is not recommended for use during pregnancy.
Testolactone Breastfeeding Warnings
There are no data on the excretion of testolactone into human milk. Testolactone is intended for use only in postmenopausal women. If the physician does wish to use this medication in a lactating women, it should be taken into account that because many drugs are excreted in human milk and because of the potential for serious adverse reactions due to testolactone in nursing infants, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug to the mother.
See also
References for pregnancy information
- "Product Information. Teslac (testolactone)." Bristol-Myers Squibb (2001):
References for breastfeeding information
- "Product Information. Teslac (testolactone)." Bristol-Myers Squibb (2001):
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.